Spot: 2D-001YH8 (lymphocyte_human)
pI: 6.74 Mw: 20794
================
*STMN1_HUMAN*
accession n°: P16949
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)ASGQAFELILSPR(S) }
Spot: 2D-001YA9 (lymphocyte_human)
pI: 5.38 Mw: 32068
%vol: 0.278829 %od: 0.217179
================
*CAZA1_HUMAN*
accession n°: P52907
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 937.449 (0), 1197.6772 (0), 2088.961 (0), 2245.0214 (0)
}
Spot: 2D-001YCI (lymphocyte_human)
pI: 7.33 Mw: 26611
%vol: 0.162699 %od: 0.123529
================
*PGAM1_HUMAN*
accession n°: P18669
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1059.5708 (0), 1150.6889 (0), 1312.6147 (0), 2115.0706 (0),
2131.1075 (0) }
Spot: 2D-001YE9 (lymphocyte_human)
pI: 7.53 Mw: 22696
%vol: 0.120787 %od: 0.0999226
================
*SODM_HUMAN*
accession n°: P04179
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 971.43579 (0), 1004.5364 (0), 1028.5896 (0), 1090.4984 (0),
1424.7871 (0), 1738.8435 (0) }
Spot: 2D-001YBM (lymphocyte_human)
pI: 5.00 Mw: 28462
%vol: 0.136504 %od: 0.0825762
================
*EFHD2_HUMAN*
accession n°: Q96C19
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)AAAGELQEDSGLCVLAR(L);; $m/Z=(R)LSEIDVSSEGVK(G);; $m/Z=(R)ADLNQGIGEPQSPSR(R);; $m/Z=(R)DGFIDLMoxELK(L) }
Spot: 2D-001YGX (lymphocyte_human)
pI: 6.83 Mw: 15152
%vol: 0.0235753 %od: 0.0136892
================
*B2MG_HUMAN*
accession n°: P61769
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)VNHVTLSQPK(I);; $m/Z=(K)VEHSDLSFSK(D) }
Spot: 2D-001YBL (lymphocyte_human)
pI: 5.10 Mw: 28586
%vol: 0.401362 %od: 0.392965
================
*CLIC1_HUMAN*
accession n°: O00299
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 957.49928 (0), 1037.56028 (0), 1095.64428 (0), 1844.97428 (0),
2233.07628 (0) }
Spot: 2D-001XZ0 (lymphocyte_human)
pI: 5.40 Mw: 43724
%vol: 0.40631 %od: 0.242677
================
*TCPE_HUMAN*
accession n°: P48643
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.5052 (0), 1183.6678 (0), 1274.6411 (0), 1610.8752 (0),
1738.9072 (0) }
Spot: 2D-001YF1 (lymphocyte_human)
pI: 5.73 Mw: 18638
%vol: 0.112929 %od: 0.0598397
================
*SODC_HUMAN*
accession n°: P00441
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)HVGDLGNVTADK(D);; $m/Z=(K)GDGPVQGIINFEQK(E) }
Spot: 2D-001YEJ (lymphocyte_human)
pI: 5.41 Mw: 22317
%vol: 0.22935 %od: 0.128305
================
*PRDX2_HUMAN*
accession n°: P32119
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 862.50838 (0), 924.46007 (0), 972.54725 (0), 978.50386 (0),
1023.5095 (0), 1179.6358 (0), 1211.6889 (0), 1734.985 (0),
1863.0792 (0) }
Spot: 2D-001YA2 (lymphocyte_human)
pI: 7.92 Mw: 32277
%vol: 0.346644 %od: 0.367951
================
*VDAC2_HUMAN*
accession n°: P45880
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 940.46628 (0), 1293.64928 (0), 1428.66828 (0), 2103.16928 (0),
2528.22428 (0) }
Spot: 2D-001Y1U (lymphocyte_human)
pI: 4.62 Mw: 42853
%vol: 0.198207 %od: 0.102947
================
*LSP1_HUMAN*
accession n°: P33241
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1647.8418 (0), 1974.9857 (0), 1977.9033 (0), 2022.001 (0),
2064.9292 (0), 2864.1504 (0) }
Spot: 2D-001YGA (lymphocyte_human)
pI: 4.74 Mw: 16099
%vol: 0.0555911 %od: 0.0396992
================
*THIO_HUMAN*
accession n°: P10599
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)TAFQEALDAAGDK(L) }
================
*H4_HUMAN*
accession n: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)TVTAMoxDVVYALK(R);; $m/Z=(R)ISGLIYEETR(G) }
Spot: 2D-001YDK (lymphocyte_human)
pI: 5.47 Mw: 24400
%vol: 0.0553001 %od: 0.0305624
================
*PSB4_HUMAN*
accession n°: P28070
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-001YGK (lymphocyte_human)
pI: 6.90 Mw: 15777
%vol: 0.0555911 %od: 0.0406711
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)VFLENVIR(D);; $m/Z=(R)DNIQGITKPAIR(R);; $m/Z=(R)DAVTYTEHAK(R);; $m/Z=(R)ISGLIYEETR(G) }
Spot: 2D-001YBO (lymphocyte_human)
pI: 5.47 Mw: 28216
%vol: 0.158915 %od: 0.137231
================
*CAPZB_HUMAN*
accession n°: P47756
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1057.59928 (0), 1108.63728 (0), 1171.58028 (0), 1231.54828 (0),
1534.67928 (0), 1568.71428 (0), 1696.82928 (0)
}
Spot: 2D-001Y0C (lymphocyte_human)
pI: 4.49 Mw: 43286
%vol: 0.162408 %od: 0.167122
================
*LSP1_HUMAN*
accession n°: P33241
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1647.8418 (0), 1974.9857 (0), 1977.9033 (0), 2022.001 (0),
2064.9292 (0), 2864.1504 (0) }
Spot: 2D-001YA1 (lymphocyte_human)
pI: 5.40 Mw: 32417
%vol: 0.161825 %od: 0.107231
================
*CAZA1_HUMAN*
accession n°: P52907
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 937.449 (0), 1197.6772 (0), 2088.961 (0), 2245.0214 (0)
}
Spot: 2D-001YBD (lymphocyte_human)
pI: 4.91 Mw: 29086
%vol: 0.156004 %od: 0.105114
================
*EFHD2_HUMAN*
accession n°: Q96C19
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)AAAGELQEDSGLCVLAR(L);; $m/Z=(R)DGFIDLMoxELK(L);; $m/Z=(R)VFNPYTEFK(E);; $m/Z=(R)ADLNQGIGEPQSPSR(R);; $m/Z=(K)VQAINVSSR(F);; $m/Z=(R)LSEIDVSSEGVK(G) }
Spot: 2D-001YG0 (lymphocyte_human)
pI: 7.63 Mw: 16594
%vol: 0.227604 %od: 0.198777
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* NORMAL LEVEL, MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1126.6138 (0), 1274.7705 (0), 1314.7063 (0), 1378.7344 (0),
1669.9066 (0), 1776.9864 (0), 1797.9638 (0), 2074.9416 (0)
}
Spot: 2D-001YC7 (lymphocyte_human)
pI: 5.64 Mw: 27372
%vol: 0.145817 %od: 0.1016
================
*PSME1_HUMAN*
accession n°: Q06323
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)QLVHELDEAEYR(D);; $m/Z=(K)QPHVGDYR(Q);; $m/Z=(K)IVVLLQR(L);; $m/Z=(K)LEGFHTQISK(Y) }
Spot: 2D-001YFY (lymphocyte_human)
pI: 5.16 Mw: 16734
%vol: 0.0101869 %od: 0.00445649
================
*TBCA_HUMAN*
accession n°: O75347
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)LEAAYLDLQR(I);; $m/Z=(K)QAEILQESR(M);; $m/Z=(R)RLEAAYLDLQR(I) }
================
*H2A1J_HUMAN*
accession n: P99059
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)AGLQFPVGR(V);; $m/Z=(R)HLQLAIR(N) }
Spot: 2D-001Y0D (lymphocyte_human)
pI: 4.94 Mw: 43308
%vol: 0.20723 %od: 0.20267
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)FLEQQNK(I);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(R)QDVDNASLAR(L);; $m/Z=(K)KVESLQEEIAFLK(K) }
Spot: 2D-001Y54 (lymphocyte_human)
pI: 7.10 Mw: 41062
%vol: 0.27388 %od: 0.208279
================
*EFTU_HUMAN*
accession n°: P49411
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)LLDAVDTYIPVPAR(D);; $m/Z=(K)ELAMoxPGEDLK(F);; $m/Z=(R)IILPPEKELAMoxPGEDLK(F);; $m/Z=(R)IILPPEK(E);; $m/Z=(K)VEAQVYILSK(E);; $m/Z=(R)GTVVTGTLER(G) }
Spot: 2D-001YBH (lymphocyte_human)
pI: 4.66 Mw: 28835
%vol: 0.346644 %od: 0.216642
================
*TPM3_HUMAN*
accession n°: P06753
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 894.44328 (0), 940.43828 (0), 1072.52428 (0), 1156.63528 (0),
1243.65228 (0), 1284.74028 (0), 1316.64028 (0), 1399.76328 (0),
1642.80028 (0), 1770.89728 (0) }
Spot: 2D-001YDB (lymphocyte_human)
pI: 7.24 Mw: 25043
%vol: 0.248559 %od: 0.196872
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 954.4686 (0), 1082.5631 (0), 1137.5636 (0), 1234.6166 (0),
1326.6824 (0), 1458.7152 (0), 1466.7069 (0), 1542.8403 (0),
1586.7368 (0), 1614.8172 (0), 2192.061 (0) }
Spot: 2D-001YD7 (lymphocyte_human)
pI: 7.38 Mw: 25207
%vol: 0.45317 %od: 0.579549
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 954.4686 (0), 1082.5631 (0), 1137.5636 (0), 1234.6166 (0),
1326.6824 (0), 1458.7152 (0), 1466.7069 (0), 1542.8403 (0),
1586.7368 (0), 1602.776 (0), 1614.8172 (0), 1637.7974 (0),
2192.061 (0) }
Spot: 2D-001YF4 (lymphocyte_human)
pI: 7.95 Mw: 18389
%vol: 0.465394 %od: 1.62247
================
*COF1_HUMAN*
accession n°: P23528
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 876.42 (0), 1050.5 (0), 1309.7 (0), 1337.7 (0), 1340.76 (0),
1519.69 (0), 1790.86 (0), 1990.07 (0), 2166.09 (0)
}
Spot: 2D-001YD3 (lymphocyte_human)
pI: 4.81 Mw: 25592
%vol: 0.123116 %od: 0.0782156
================
*CPNS1_HUMAN*
accession n°: P04632
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)THYSNIEANESEEVR(Q);; $m/Z=(K)TDGFGIDTCR(S) }
Spot: 2D-001Y9E (lymphocyte_human)
pI: 6.95 Mw: 33854
%vol: 0.394668 %od: 0.479593
================
*ENOA_HUMAN*
accession n°: P06733
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1143.5926 (0), 1425.6797 (0), 1556.7592 (0), 1804.9472 (0),
1939.978 (0), 1960.9184 (0) }
Spot: 2D-001YE4 (lymphocyte_human)
pI: 6.44 Mw: 23198
%vol: 0.157459 %od: 0.13814
================
*PRDX3_HUMAN*
accession n°: P30048
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)HLSVNDLPVGR(S);; $m/Z=(R)DYGVLLEGSGLALR(G) }
Spot: 2D-001YH7 (lymphocyte_human)
pI: 4.22 Mw: 16594
================
*CALM_HUMAN*
accession n°: P62158
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.49 (0), 1265.64 (0), 1596.72 (0), 1754.88 (0), 1844.9 (0)
}
Spot: 2D-001Y0I (lymphocyte_human)
pI: 5.06 Mw: 43286
%vol: 0.304441 %od: 0.617604
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)FADLSEAANR(N);; $m/Z=(R)ETNLDSLPLVDTHSK(R);; $m/Z=(R)ISLPLPNFSSLNLR(E);; $m/Z=(R)KLLEGEESR(I);; $m/Z=(K)MALDIEIATYR(K);; $m/Z=(R)EMEENFAVEAANYQDTIGR(L);; $m/Z=(R)QVQSLTCEVDALK(G);; $m/Z=(R)QQYESVAAK(N);; $m/Z=(K)KVESLQEEIAFLK(K);; $m/Z=(R)QDVDNASLARLDLER(K);; $m/Z=(K)LQEEMLQR(E);; $m/Z=(R)LGDLYEEEMR(E);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(K)VELQELNDR(F);; $m/Z=(R)TYSLGSALRPSTSR(S);; $m/Z=(R)SYVTTSTR(T);; $m/Z=(R)SVSSSSYR(R);; $m/Z=(R)DGQVINETSQHHDDLE() }
================
*TBA1B_HUMAN*
accession n: P68363
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)VGINYQPPTVVPGGDLAK(V);; $m/Z=(K)TIGGGDDSFNTFFSETGAGK(H);; $m/Z=(R)QLFHPEQLITGK(E);; $m/Z=(R)LISQIVSSITASLR(F);; $m/Z=(R)IHFPLATYAPVISAEK(A);; $m/Z=(R)SIQFVDWCPTGFK(V) }
Spot: 2D-001YFN (lymphocyte_human)
pI: 4.35 Mw: 17424
%vol: 0.0980849 %od: 0.0465021
================
*MYL6_HUMAN*
accession n°: P60660
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1025.5118 (0), 1354.731 (0), 1544.674 (0), 1786.789 (0),
1904.0164 (0) }
Spot: 2D-001YDX (lymphocyte_human)
pI: 5.43 Mw: 23712
%vol: 0.347808 %od: 0.220126
================
*GSTP1_HUMAN*
accession n°: P09211
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1337.7509 (0), 1883.9496 (0), 2116.9846 (0), 2126.166 (0),
2132.9847 (0), 2155.0385 (0) }
Spot: 2D-001YF9 (lymphocyte_human)
pI: 5.44 Mw: 18173
%vol: 0.0445311 %od: 0.035652
================
*ARPC5_HUMAN*
accession n°: O15511
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)GFESPSDNSSAMoxLLQWHEK(A);; $m/Z=(K)ALAAGGVGSIVR(V);; $m/Z=(R)QGNMoxTAALQAALK(N) }
Spot: 2D-001YCJ (lymphocyte_human)
pI: 6.85 Mw: 26554
%vol: 0.277083 %od: 0.266943
================
*PGAM1_HUMAN*
accession n°: P18669
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1059.5708 (0), 1150.6889 (0), 1312.6147 (0), 2115.0706 (0),
2131.1075 (0) }
Spot: 2D-001YG3 (lymphocyte_human)
pI: 4.75 Mw: 16427
%vol: 0.0791664 %od: 0.0611696
================
*COX5A_HUMAN*
accession n°: P20674
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1607.6572 (0), 1692.8538 (0), 2052.9844 (0), 3428.8217 (0)
}
Spot: 2D-001YER (lymphocyte_human)
pI: 5.39 Mw: 20864
%vol: 0.0928459 %od: 0.0801529
================
*APT_HUMAN*
accession n°: P07741
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 885.4662 (0), 1122.5808 (0), 1444.7787 (0), 1465.7419 (0)
}
Spot: 2D-001YEO (lymphocyte_human)
pI: 7.76 Mw: 21614
%vol: 0.140579 %od: 0.09514
================
*PEBP1_HUMAN*
accession n°: P30086
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1454.699 (0), 1559.825 (0), 1631.814 (0), 1707.901 (0),
1773.862 (0), 2068.95 (0), 3470.687 (0) }
Spot: 2D-001YH2 (lymphocyte_human)
pI: 8.02 Mw: 15000
%vol: 0.0238663 %od: 0.0217901
================
*S10AA_HUMAN*
accession n°: P60903
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)EFPGFLENQKDPLAVDK(I);; $m/Z=(K)EFPGFLENQK(D) }
Spot: 2D-001Y7K (lymphocyte_human)
pI: 7.89 Mw: 37732
%vol: 0.334711 %od: 0.415566
================
*ALDOA_HUMAN*
accession n°: P04075
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1068.5528 (0), 1093.5656 (0), 1342.7089 (0), 1646.8045 (0),
1675.8394 (0), 1691.8279 (0), 2107.1055 (0), 2123.107 (0),
3176.6785 (0) }
Spot: 2D-001YCA (lymphocyte_human)
pI: 5.48 Mw: 27195
%vol: 0.15193 %od: 0.126061
================
*CAPZB_HUMAN*
accession n°: P47756
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1057.59928 (0), 1108.63728 (0), 1171.58028 (0), 1231.54828 (0),
1534.67928 (0), 1568.71428 (0), 1696.82928 (0)
}
Spot: 2D-001YG9 (lymphocyte_human)
pI: 7.55 Mw: 16153
%vol: 0.098667 %od: 0.0696415
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* NORMAL LEVEL, MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1126.5561 (0), 1274.733 (0), 1314.6739 (0), 1669.883 (0)
}
Spot: 2D-001YG6 (lymphocyte_human)
pI: 5.27 Mw: 16317
%vol: 0.0451132 %od: 0.029028
================
*SH3L1_HUMAN*
accession n°: O75368
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1159.5898 (0), 1190.5125 (0), 1848.9669 (0), 3003.4913 (0)
}
Spot: 2D-001YGB (lymphocyte_human)
pI: 7.94 Mw: 16072
%vol: 0.0855696 %od: 0.112979
================
*DOPD_HUMAN*
accession n°: P30046
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)SHSAHFFEFLTK(E);; $m/Z=(-)PFLELDTNLPANR(V) }
Spot: 2D-001YCL (lymphocyte_human)
pI: 5.40 Mw: 26439
%vol: 0.261947 %od: 0.162569
================
*PHB_HUMAN*
accession n°: P35232
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1058.5842 (0), 1149.6272 (0), 1185.6994 (0), 1396.8822 (0),
1444.6952 (0), 1606.8848 (0), 1998.1261 (0) }
Spot: 2D-001YGW (lymphocyte_human)
pI: 5.42 Mw: 15461
%vol: 0.213051 %od: 0.295567
================
*S10A4_HUMAN*
accession n°: P26447
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 890.48408 (0), 1049.5066 (0), 1065.5346 (0), 1247.6626 (0),
1263.6426 (0) }
Spot: 2D-001Y2I (lymphocyte_human)
pI: 4.97 Mw: 42552
%vol: 0.481402 %od: 0.852539
================
*ATPB_HUMAN*
accession n°: P06576
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 975.46428 (0), 1038.5 (0), 1262.5659 (0), 1278.6003 (0),
1385.6373 (0), 1401.6378 (0), 1406.6121 (0), 1435.6911 (0),
1439.7253 (0), 1601.7664 (0), 1617.7455 (0), 1650.8752 (0),
1815.8459 (0), 1831.8573 (0), 1919.0973 (0), 1921.9578 (0),
1988.0279 (0), 2039.022 (0), 2266.1179 (0), 2282.1443 (0),
2675.4246 (0) }
Spot: 2D-001XZF (lymphocyte_human)
pI: 4.65 Mw: 43614
%vol: 0.352174 %od: 0.299032
================
*PDIA1_HUMAN*
accession n°: P07237
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 870.43532 (0), 905.4054 (0), 910.4519 (0), 1066.4867 (0),
1451.7173 (0), 1459.7071 (0), 1521.7765 (0), 1780.8465 (0),
1833.9008 (0) }
Spot: 2D-001YC6 (lymphocyte_human)
pI: 5.52 Mw: 27491
%vol: 0.0756738 %od: 0.0550851
================
*3HIDH_HUMAN*
accession n°: P31937
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)TPVGFIGLGNMoxGNPMoxAK(N);; $m/Z=(K)EFQDAGEQVVSSPADVAEK(A);; $m/Z=(K)DLGLAQDSATSTK(S);; $m/Z=(K)MoxGAVFMoxDAPVSGGVGAAR(S);; $m/Z=(K)MGAVFMDAPVSGGVGAAR(S) }
Spot: 2D-001YD5 (lymphocyte_human)
pI: 6.73 Mw: 25482
%vol: 0.273299 %od: 0.173726
================
*PRDX6_HUMAN*
accession n°: P30041
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 906.4809 (0), 1045.564 (0), 1085.6079 (0), 1191.692 (0),
1395.6768 (0), 2098.0915 (0) }
Spot: 2D-001YDQ (lymphocyte_human)
pI: 5.03 Mw: 23952
%vol: 0.374585 %od: 0.646581
================
*GDIR2_HUMAN*
accession n°: P52566
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 855.49563 (0), 966.47328 (0), 967.47607 (0), 1084.5995 (0),
1311.7 (0), 1692.781 (0), 1708.7637 (0), 1939.7943 (0)
}
Spot: 2D-001YD0 (lymphocyte_human)
pI: 6.60 Mw: 25815
%vol: 0.160662 %od: 0.0836503
================
*PSB10_HUMAN*
accession n°: P40306
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1130.5751 (0), 1214.6538 (0), 1861.8171 (0), 1947.0312 (0),
2044.0499 (0) }
Spot: 2D-001YG7 (lymphocyte_human)
pI: 4.94 Mw: 16289
%vol: 0.104779 %od: 0.0513232
================
*LEG1_HUMAN*
accession n°: P09382
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)VRGEVAPDAK(S);; $m/Z=(K)SFVLNLGK(D);; $m/Z=(K)DSNNLCLHFNPR(F);; $m/Z=(K)DGGAWGTEQR(E);; $m/Z=(R)FNAHGDANTIVCNSK(D);; $m/Z=(K)LPDGYEFK(F) }
Spot: 2D-001YFJ (lymphocyte_human)
pI: 4.26 Mw: 17661
%vol: 0.0456953 %od: 0.0251418
================
*CALM_HUMAN*
accession n°: P62158
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.49 (0), 1265.64 (0), 1596.72 (0), 1754.88 (0), 1844.9 (0)
}
Spot: 2D-001Y95 (lymphocyte_human)
pI: 8.02 Mw: 34002
%vol: 0.351301 %od: 1.41754
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 912.3925 (0), 1013.4416 (0), 1050.4377 (0), 1165.5331 (0),
1188.6545 (0), 1338.7199 (0), 1377.6368 (0), 1695.7759 (0),
1798.9199 (0), 1927.014 (0), 2189.944 (0), 2205.93 (0)
}
Spot: 2D-001XX7 (lymphocyte_human)
pI: 4.29 Mw: 44500
%vol: 0.270388 %od: 0.211341
================
*CALR_HUMAN*
accession n°: P27797
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 853.434 (0), 887.3898 (0), 906.4702 (0), 927.4915 (0),
975.4933 (0), 1019.5579 (0), 1045.564 (0), 1047.5083 (0),
1130.5341 (0), 1147.6566 (0), 1219.6814 (0), 1410.6379 (0),
1476.6938 (0), 1607.7465 (0), 1800.8494 (0) }
Spot: 2D-001YH6 (lymphocyte_human)
pI: 4.18 Mw: 30178
================
*AN32A_HUMAN*
accession n°: P39687
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 936.55632 (0), 945.49173 (0), 974.51148 (0), 1101.6071 (0),
1566.8482 (0), 1924.9984 (0), 1972.95 (0) }
Spot: 2D-001YFD (lymphocyte_human)
pI: 7.82 Mw: 17900
%vol: 0.352465 %od: 0.412426
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1055.5352 (0), 1154.5587 (0), 1247.6071 (0), 1310.5507 (0),
1379.7348 (0), 1423.735 (0), 1537.7165 (0), 1614.7363 (0),
1831.906 (0), 1946.0415 (0) }
Spot: 2D-001Y97 (lymphocyte_human)
pI: 8.23 Mw: 34075
%vol: 0.448222 %od: 1.58791
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1799.0071 (0), 1880.0531 (0), 1927.0633 (0), 2189.9327 (0),
2205.9229 (0), 2220.0717 (0), 2495.0023 (0) }
Spot: 2D-001YG4 (lymphocyte_human)
pI: 7.11 Mw: 16455
%vol: 0.0279411 %od: 0.0270651
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)ISGLIYEETR(G);; $m/Z=(R)DNIQGITKPAIR(R);; $m/Z=(K)VFLENVIR(D) }
Spot: 2D-001YDC (lymphocyte_human)
pI: 7.00 Mw: 25098
%vol: 0.148146 %od: 0.0936055
================
*TPIS_HUMAN*
accession n°: P60174
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1082.5862 (0), 1234.6576 (0), 1458.7059 (0), 1466.7165 (0),
1586.7503 (0), 1614.8234 (0), 2192.068 (0) }
Spot: 2D-001Y4T (lymphocyte_human)
pI: 5.29 Mw: 41600
%vol: 0.503522 %od: 0.992934
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-001YE5 (lymphocyte_human)
pI: 5.99 Mw: 23159
%vol: 0.104488 %od: 0.041886
================
*ABHEB_HUMAN*
accession n°: Q96IU4
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)AVAIDLPGLGHSK(E);; $m/Z=(R)FSSETWQNLGTLHR(L);; $m/Z=(R)FSVLLLHGIR(F);; $m/Z=(R)EGTIQVQGQALFFR(E) }
Spot: 2D-001Y0H (lymphocyte_human)
pI: 4.99 Mw: 43286
%vol: 0.274754 %od: 0.356813
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* EXPRESSION, MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)RQVDQLTNDK(A);; $m/Z=(K)ILLAELEQLK(G);; $m/Z=(R)FANYIDK(V);; $m/Z=(R)TYSLGSALRPSTSR(S);; $m/Z=(K)MALDIEIATYR(K);; $m/Z=(K)LLEGEESR(I);; $m/Z=(R)QVQSLTCEVDALK(G);; $m/Z=(K)FADLSEAANR(N);; $m/Z=(R)QQYESVAAK(N);; $m/Z=(K)LQEEMLQR(E);; $m/Z=(R)QVDQLTNDK(A) }
================
*DESM_HUMAN*
accession n: P17661
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)LLEGEESR(I);; $m/Z=(R)KLLEGEESR(I);; $m/Z=(R)VSSYRR(T) }
Spot: 2D-001YDL (lymphocyte_human)
pI: 6.00 Mw: 24400
%vol: 0.0654869 %od: 0.0320329
================
*GRB2_HUMAN*
accession n°: P62993
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 918.51121 (0), 928.46921 (0), 962.48723 (0), 1091.5116 (0),
1212.6374 (0), 1452.678 (0), 1506.7351 (0) }
Spot: 2D-001Y9I (lymphocyte_human)
pI: 5.67 Mw: 33781
%vol: 0.408347 %od: 0.374059
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-001Y35 (lymphocyte_human)
pI: 7.37 Mw: 42232
%vol: 0.409221 %od: 0.705379
================
*ENOA_HUMAN*
accession n°: P06733
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1143.5926 (0), 1425.6797 (0), 1556.7592 (0), 1804.9472 (0),
1939.978 (0), 1960.9184 (0) }
Spot: 2D-001YFH (lymphocyte_human)
pI: 7.31 Mw: 17780
%vol: 0.016881 %od: 0.0117582
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1055.5352 (0), 1154.5587 (0), 1247.6071 (0), 1310.5507 (0),
1379.7348 (0), 1423.735 (0), 1537.7165 (0), 1614.7363 (0),
1831.906 (0), 1946.0415 (0) }
Spot: 2D-001Y2J (lymphocyte_human)
pI: 4.83 Mw: 42552
%vol: 0.0838233 %od: 0.107765
================
*TBB5_HUMAN*
accession n°: P07437
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1028.5099 (0), 1077.5322 (0), 1130.6085 (0), 1143.623 (0),
1159.616 (0), 1615.8306 (0), 1958.9764 (0) }
Spot: 2D-001Y94 (lymphocyte_human)
pI: 7.86 Mw: 34149
%vol: 0.229641 %od: 0.685801
================
*ROA2_HUMAN*
accession n°: P22626
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1013.44 (0), 1050.42 (0), 1188.63 (0), 1377.63 (0), 1410.68 (0),
1798.93 (0), 1927.01 (0) }
Spot: 2D-001Y0Q (lymphocyte_human)
pI: 5.70 Mw: 43221
%vol: 0.487514 %od: 0.379608
================
*PDIA3_HUMAN*
accession n°: P30101
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 869.4443 (0), 877.4562 (0), 995.5615 (0), 1084.5668 (0),
1172.5655 (0), 1188.536 (0), 1191.6128 (0), 1236.5323 (0),
1341.678 (0), 1359.6649 (0), 1370.7103 (0), 1515.8008 (0),
1680.8153 (0), 2575.3526 (0), 2703.3885 (0) }
Spot: 2D-001YF6 (lymphocyte_human)
pI: 6.63 Mw: 18327
%vol: 0.397578 %od: 0.356968
================
*COF1_HUMAN*
accession n°: P23528
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)AVLFCLSEDKK(N);; $m/Z=(K)MoxLPDKDCR(Y);; $m/Z=(R)YALYDATYETK(E) }
Spot: 2D-001YCK (lymphocyte_human)
pI: 4.55 Mw: 26669
%vol: 0.121951 %od: 0.125594
================
*PSA5_HUMAN*
accession n°: P28066
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)GPQLFHMoxDPSGTFVQCDAR(A);; $m/Z=(K)LNATNIELATVQPGQNFHMoxFTK(E);; $m/Z=(R)ITSPLMEPSSIEK(I);; $m/Z=(R)ITSPLMoxEPSSIEK(I);; $m/Z=(K)IVEIDAHIGCAMoxSGLIADAK(T);; $m/Z=(R)AIGSASEGAQSSLQEVYHK(S) }
Spot: 2D-001YCY (lymphocyte_human)
pI: 6.79 Mw: 25871
%vol: 0.158042 %od: 0.105002
================
*PSA6_HUMAN*
accession n°: P60900
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1156.6144 (0), 1160.5792 (0), 1285.7352 (0), 1360.7116 (0),
1979.0477 (0) }
Spot: 2D-001Y9S (lymphocyte_human)
pI: 5.67 Mw: 33200
%vol: 0.311427 %od: 0.197115
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
 |
SWISS-2DPAGE Viewer LYMPHOCYTE_HUMAN { Lymphocytes } (All identified proteins)
|
| |
|
 |
